The participants receive a subcutaneous injection every 4 weeks
Sponsors
Shire
Conditions
a type of IBD that may affect any part of the gastroinestinal tract from mouth to anus
Crohn's Diseasea type of IBD that may affect any part of the gastrointestinal tract from mouth to anus
Crohn's Diseasechronic inflammation of the mucosa of the colon and rectum
Ulcerative Colitischronic inflammationof the mucosa of the colon and rectum
Ulcerative Colitis
Phase 3
A Phase 3 Randomized, Double-blind, Placebo controlled, Parallel group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Active, not recruitingNL-OMON50472
Start: 2019-02-11Target: 14Updated: 2025-08-18
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects with Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Active, not recruitingNL-OMON50514
Start: 2018-09-19Target: 29Updated: 2025-08-18
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn*s Disease (CARMEN CD 307)
Active, not recruitingNL-OMON50298
Start: 2020-02-18Target: 7Updated: 2025-08-18
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn*s Disease (CARMEN CD 305)
Active, not recruitingNL-OMON50376
Start: 2019-10-02Target: 14Updated: 2025-08-18